TD Asset Management’s Prime Medicine PRME Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $56.6K | Sell |
22,910
-23,524
| -51% | -$58.1K | ﹤0.01% | 1188 |
|
|
2025
Q1 | $92.4K | Hold |
46,434
| – | – | ﹤0.01% | 1210 |
|
|
2024
Q4 | $136K | Hold |
46,434
| – | – | ﹤0.01% | 1236 |
|
|
2024
Q3 | $161K | Hold |
46,434
| – | – | ﹤0.01% | 1372 |
|
|
2024
Q2 | $239K | Sell |
46,434
-82,588
| -64% | -$425K | ﹤0.01% | 1331 |
|
|
2024
Q1 | $903K | Buy |
129,022
+76,280
| +145% | +$534K | ﹤0.01% | 1182 |
|
|
2023
Q4 | $467K | Sell |
52,742
-51,800
| -50% | -$459K | ﹤0.01% | 1310 |
|
|
2023
Q3 | $997K | Buy |
104,542
+37,471
| +56% | +$357K | ﹤0.01% | 1142 |
|
|
2023
Q2 | $983K | Buy |
67,071
+43,149
| +180% | +$632K | ﹤0.01% | 1137 |
|
|
2023
Q1 | $294K | Hold |
23,922
| – | – | ﹤0.01% | 1345 |
|
|
2022
Q4 | $444K | Buy |
+23,922
| New | +$444K | ﹤0.01% | 1304 |
|